Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

Clinical trial NCT05620342 · RECRUITING

Trial details

NCT number: NCT05620342
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lung Cancer Small Cell Lung Carcinoma Non Small Cell Lung Cancer

Start date: 2023-06-21
Primary completion: 2027-11-24
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.